GLI1 and cancer: Overall these findings substantiate the importance of GLI as a target in cancers with activated GLI and/or oncogenic KRAS/BRAF signaling, and that inhibition of GLI-dependent transcription by a specific small molecule inhibitor can have profound effects on cell survival.